| NRM | Relapse | Chronic GVHD | |||
---|---|---|---|---|---|---|
Factor | HR (95Â % CI) | P value | HR (95Â % CI) | P value | HR (95Â % CI) | P value |
RIC vs. MAC | 0.56 (0.43–0.74) | 0.0004 | 1.19 (0.95–1.49) | 0.13 | 1.19 (0.95–1.49) | 0.12 |
CR2 vs. CR1 | 1.35 (0.96–1.90) | 0.09 | 1.68 (1.26–2.23) | 0.0004 | 1.10 (0.82–1.46) | 0.53 |
Advanced vs. CR1 | 1.61 (1.19–2.17) | 0.002 | 2.71 (2.17–3.38) | <0.00001 | 1.42 (1.08–1.85) | 0.01 |
In vivo T cell depletion | 0.85 (0.62–1.17) | 0.33 | 1.35 (1.09–1.68) | 0.01 | 0.62 (0.49–0.80) | 0.0002 |
Age > 55 years | 1.46 (1.13–1.89) | 0.004 | 1.45 (1.13–1.89) | 0.0004 | 1.00 (0.82–1.23) | 0.99 |
F → M | 1.41 (1.09–1.83) | 0.01 | 1.03 (0.83–1.28) | 0.78 | 1.11 (0.89–1.38) | 0.37 |
Cytogenetics | ||||||
 Intermediate vs. good | 0.73 (0.46–1.16) | 0.18 | 1.70 (1.01–2.86) | 0.05 | 0.76 (0.53–1.11) | 0.16 |
 Poor vs. good | 0.63 (0.35–1.13) | 0.12 | 3.36 (1.94–5.84) | 0.0002 | 0.71 (0.45–1.11) | 0.13 |
 Missing | 0.77 (0.46–1.27) | 0.31 | 1.67 (0.96–2.91) | 0.07 | 0.78 (0.51–1.21) | 0.27 |
Year of SCT | 0.96 (0.91–1.01) | 0.12 | 0.98 (0.93–1.02) | 0.30 | 1.01 (0.97–1.06) | 0.58 |
Patient CMV + | 1.22 (0.92–1.61) | 0.17 | 0.94 (0.75–1.17) | 0.56 | 0.99 (0.80–1.23) | 0.95 |
Donor CMV + | 0.88 (0.68–1.14) | 0.33 | 1.03 (0.84–1.27) | 0.79 | 0.98 (0.80–1.21) | 0.87 |
PBSC vs. BM | 0.90 (0.66–1.24) | 0.53 | 0.80 (0.61–1.05) | 0.10 | 1.45 (1.08–1.95) | 0.01 |